264 related articles for article (PubMed ID: 17661735)
21. Nebivolol: endothelium-mediated vasodilating effect.
Ritter JM
J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
[TBL] [Abstract][Full Text] [Related]
22. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
Coats AJ
Drugs Aging; 2006; 23(2):93-9. PubMed ID: 16536633
[TBL] [Abstract][Full Text] [Related]
23. Nebivolol: a third-generation beta-adrenergic blocker.
Veverka A; Nuzum DS; Jolly JL
Ann Pharmacother; 2006; 40(7-8):1353-60. PubMed ID: 16822893
[TBL] [Abstract][Full Text] [Related]
24. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
[TBL] [Abstract][Full Text] [Related]
25. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
[TBL] [Abstract][Full Text] [Related]
26. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
Gromnatskiĭ NI; Dius'mikeeva NB
Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
[TBL] [Abstract][Full Text] [Related]
27. Nebivolol for the treatment of heart failure.
Dery AS; Hamilton LA; Starr JA
Am J Health Syst Pharm; 2011 May; 68(10):879-86. PubMed ID: 21546638
[TBL] [Abstract][Full Text] [Related]
28. Vasodilating versus first-generation β-blockers for cardiovascular protection.
Fares H; Lavie CJ; Ventura HO
Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary effects of nebivolol.
Dal Negro R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
[TBL] [Abstract][Full Text] [Related]
31. The effects of newer beta-adrenoceptor antagonists on vascular function in cardiovascular disease.
Wehland M; Grosse J; Simonsen U; Infanger M; Bauer J; Grimm D
Curr Vasc Pharmacol; 2012 May; 10(3):378-90. PubMed ID: 22022769
[TBL] [Abstract][Full Text] [Related]
32. The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol.
Bakris GL; Basile JN; Giles TD; Taylor AA
Am J Med; 2010 Jul; 123(7 Suppl 1):S2-8. PubMed ID: 20609695
[TBL] [Abstract][Full Text] [Related]
33. β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
Ambrosio G; Flather MD; Böhm M; Cohen-Solal A; Murrone A; Mascagni F; Spinucci G; Conti MG; van Veldhuisen DJ; Tavazzi L; Coats AJ
Heart; 2011 Feb; 97(3):209-14. PubMed ID: 21138861
[TBL] [Abstract][Full Text] [Related]
34. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
35. Nebivolol: a new beta blocker on the horizon.
Katira R; Chauhan A
Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
[No Abstract] [Full Text] [Related]
36. Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation.
Weiss R
Vasc Health Risk Manag; 2006; 2(3):303-8. PubMed ID: 17326335
[TBL] [Abstract][Full Text] [Related]
37. The role of nebivolol in the management of hypertensive patients: from pharmacological profile to treatment guidelines.
Ferri C
Future Cardiol; 2021 Nov; 17(8):1421-1433. PubMed ID: 34060323
[TBL] [Abstract][Full Text] [Related]
38. Beta-blockade in hypertension and congestive heart failure.
Ambrosioni E; Bacchelli S; Esposti DD; Borghi C
J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S25-31. PubMed ID: 11811389
[TBL] [Abstract][Full Text] [Related]
39. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
[No Abstract] [Full Text] [Related]
40. Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial.
Uhlir O; Dvorak I; Gregor P; Malek I; Spinarova L; Vojacek J; Van Nueten L
J Card Fail; 1997 Dec; 3(4):271-6. PubMed ID: 9547441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
